Daniel-Schramek

Decoding Aneuploidy: Identifying Drivers and potential novel Therapeutic Targets in recurrent CNAs in Breast Cancer

Daniel Schramek

Lunenfeld-Tanenbaum Research Institute/Mount Sinai Hospital in Toronto

16/09/2024

12:00-

Sala Pau Viladiu / Híbrid (Enllaç)

Resum

#IDIBELLextraordinaryseminar
16 Sept,  12pm Sala Pau Viladiu
Title: Decoding Aneuploidy: Identifying Drivers and potential novel Therapeutic Targets in recurrent CNAs in Breast Cancer
Dr. Daniel Schramek
Senior Investigator – Deputy Director
Lunenfeld-Tanenbaum Research Institute/Mount Sinai Hospital in Toronto
Associate Professor – Department of Molecular Genetics
Temerty Faculty of Medicine
University of Toronto

Hosted by Miquel Àngel Pujana – Breast Cancer group

Biografia

Dr. Daniel Schramek is a Senior Investigator and the Deputy Director at the Lunenfeld-Tanenbaum Research Institute/Mount Sinai Hospital in Toronto, and an Associate Professor at the Department of Molecular Genetics, Temerty Faculty of Medicine, University of Toronto. He holds the inaugural Tony Pawson Sinai 100 Chair and the Canadian Research Chair in Functional Cancer Genomics. Daniel was awarded an MSc in Molecular Biology from the University of Vienna, conducting his thesis work under the supervision Prof. Roger Daly at the Garvan Institute in Sydney. Upon returning to Vienna, Daniel performed his PhD work under the supervision of Prof. Josef Penninger, before pursuing postdoctoral work with Prof. Elaine Fuchs at the Rockefeller University. His lab pioneers research in functional cancer genomics using mouse models of breast, brain, Head & Neck, and pancreatic cancer with the goal to elucidate the genetic drivers as well as genotype-specific vulnerabilities and novel drug targets to treat these fetal cancers.

Scroll to Top